Delivery Order SPE2DB24D3015-SPE2DB25FFYJT

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,513.87, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,987.20, is a delivery order for the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,988.03, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $15,060.83, is for the supply of STELARA 90 MG/ML syringes. The contract is a firm fixed-price arrangement with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,054.88, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has a completion date of February 26, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Stelara 45 mg/0.5 ml syringes. The firm-fixed-price contract has a ceiling value of $12,719.25 and a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a ceiling value of $15,917.42 and a performance period through May 12, 2023. The contract is a firm fixed-price delivery order, which is a type of Indefinite Delivery Contract (IDC) that the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 45 mg/0.5 ml syringes. The contract has a ceiling value of $5,563.16 and an ultimate completion date of September 11, 2024. The contract is a firm fixed price type and does not have a set-aside designation. Amerisourcebergen is a significant supplier of pharmaceutical products and medical supplies to various government agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $7,614.58, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of August 15, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, through its extensive supply chain network, will provide this...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,530.93, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML medical products. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of February 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYJT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a ceiling value of $11,447.59 and a period of performance through March 10, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded as a firm fixed price delivery order, with no set-aside designation.

Generated 6/6/25, 10:01 AM